Cargando…

The Clinical Effect of Metformin on the Survival of Lung Cancer Patients with Diabetes: A Comprehensive Systematic Review and Meta-analysis of Retrospective Studies

Preclinical investigations have revealed an anti-cancer effect of metformin. Several studies of metformin treatment have demonstrated the improved clinical outcomes of lung cancer patients with diabetes; however, the results have been inconsistent among studies. Our systematic review and meta-analys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Xun, Wen, Zhe-Sheng, Wang, Xu-Dong, Li, Yong, Liu, Kui-Yuan, Wang, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595083/ https://www.ncbi.nlm.nih.gov/pubmed/28900491 http://dx.doi.org/10.7150/jca.19750

Ejemplares similares

Metformin therapy associated with survival benefit in lung cancer patients with diabetes
por: Wan, Guoxing, et al.
Publicado: (2016)

The Effect of Metformin on Mortality Among Diabetic Cancer Patients: A Systematic Review and Meta-analysis
por: Cao, Xun, et al.
Publicado: (2017)

Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis
por: Zhou, Ping-Ting, et al.
Publicado: (2017)

The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis
por: Li, Yang, et al.
Publicado: (2017)

Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis
por: Meng, Fanqiang, et al.
Publicado: (2017)

Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis
por: Yao, Long, et al.
Publicado: (2019)

Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis
por: Dong, Yi-Wei, et al.
Publicado: (2017)

Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
por: Mei, Zu-Bing, et al.
Publicado: (2014)

The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study
por: Chu, Ping-Teng, et al.
Publicado: (2023)

Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs
por: Hung, Ming-Szu, et al.
Publicado: (2019)

Factors determining the survival of nasopharyngeal carcinoma with lung metastasis alone: does combined modality treatment benefit?
por: Cao, Xun, et al.
Publicado: (2011)

Metformin Increases Survival in Hypopharyngeal Cancer Patients with Diabetes Mellitus: Retrospective Cohort Study and Cell-Based Analysis
por: Tsou, Yung-An, et al.
Publicado: (2021)

The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
por: Tian, Shan, et al.
Publicado: (2017)

The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
por: Li, Xiaogang, et al.
Publicado: (2017)

Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis
por: Ma, Shu-Juan, et al.
Publicado: (2016)

Use of Metformin and Survival of Diabetic Women with Breast Cancer
por: Peeters, Paul J.H.L., et al.
Publicado: (2013)

Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study
por: Wang, Shan-Bing, et al.
Publicado: (2017)

Impact of metformin use on survival outcomes in non-small cell lung cancer treated with platinum
por: Wen-Xiu, Xin, et al.
Publicado: (2018)

Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis
por: Shi, Yu-Qi, et al.
Publicado: (2020)

Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study
por: Chuang, Min-Chun, et al.
Publicado: (2018)

Correction: Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
Publicado: (2014)

Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer
por: Arrieta, Oscar, et al.
Publicado: (2016)

Expression of Cystatin SN significantly correlates with recurrence, metastasis, and survival duration in surgically resected non-small cell lung cancer patients
por: Cao, Xun, et al.
Publicado: (2015)

Therapeutic Use of Metformin in Diabetes and Survival Outcomes in Endometrial Cancer Patients with Diabetes
por: Insin, Putsarat, et al.
Publicado: (2018)

Metformin and thyroid carcinoma incidence and prognosis: A systematic review and meta-analysis
por: Wang, Zikun, et al.
Publicado: (2022)

The effect of metformin and thiazolidinedione use on lung cancer in diabetics
por: Mazzone, Peter J, et al.
Publicado: (2012)

Impact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-Analysis
por: Kong, Wen, et al.
Publicado: (2015)

Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study
por: Wang, Qiao-Li, et al.
Publicado: (2023)

Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
por: Luo, Pan, et al.
Publicado: (2020)

Impact of metformin on survival outcome of esophageal squamous cell carcinomas patients undergoing surgical resection: a multicenter retrospective study
por: He, Huang-He, et al.
Publicado: (2020)

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
por: Garrett, C R, et al.
Publicado: (2012)

Sulfonylureas (not metformin) improve survival of patients with diabetes and resectable pancreatic adenocarcinoma
por: Toomey, Paul, et al.
Publicado: (2017)

Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma
por: Powell, Marta K., et al.
Publicado: (2019)

Prognostic value of metformin for non-small cell lung cancer patients with diabetes
por: Xu, Tongbai, et al.
Publicado: (2018)

The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus
por: Yang, Wenxing, et al.
Publicado: (2021)

The efficacy and safety of liraglutide added to metformin in patients with diabetes: a meta-analysis of randomized controlled trials
por: Gu, Jianqiu, et al.
Publicado: (2016)

Impact of Metformin Use on Survival in Patients with Gastric Cancer and Diabetes Mellitus Following Gastrectomy
por: Chung, Wai-Shan, et al.
Publicado: (2020)

The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy
por: Yuan, Bo, et al.
Publicado: (2022)

Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation
por: Farmer, Ruth E, et al.
Publicado: (2017)

Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation
por: Farmer, Ruth E, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_hek24bbilghtuk63cmp26u17qa